University Hospital Tuebingen

This study is testing the safety of adding a drug called venetoclax to a standard, lower-intensity chemotherapy regimen given before a stem cell transplant. The goal is to see if this combination can better control acute myeloid leukemia (AML) or high-risk myelodysplastic syndrom…

This study is testing a home-based training program designed to help people with Parkinson's disease who are at high risk for dementia. Participants will pedal a stationary bike while playing brain-training games on a tablet, aiming to improve both thinking skills and the ability…

This study compares two surgical methods for removing lymph nodes in the groin of men with penile cancer. It will test if a newer, robot-assisted technique causes fewer severe complications than the current standard open surgery, while still effectively controlling the cancer. Th…

This trial is testing a new type of personalized immune cell therapy (CAR-T) for advanced pancreatic cancer that has stopped responding to standard treatments. Doctors will collect a patient's own immune cells, genetically modify them to target a protein called CD318 found on pan…

This study is testing if a therapy called Lecigon, delivered directly to the intestines, is better than standard oral medications at managing the neuropsychiatric side effects that can occur with Parkinson's disease treatment. It will involve 150 adults with Parkinson's who exper…

This study aims to identify which patients are most at risk for developing confusion (called delirium) after elective heart surgery. Researchers will observe 100 adult patients to test how well a specific prediction score works. The goal is to better understand risk factors so do…